A roadmap for supporting the development of advanced therapy medicinal products in a European framework

Summary: Advanced therapy medicinal products (ATMPs) represent a paradigm shift in medicine; however, their implementation in European health systems is often hampered by EU regulations. Amidst a rapidly evolving and increasingly competitive global landscape, dominated by the US and China, it become...

Descripció completa

Dades bibliogràfiques

Autors principals:	Johan Van Eldere, Alessandro Aiuti, Silvia Martin Lluesma, Bjarne Kuno Møller, Britt Elmedal Laursen, Celeste Lebbe, Alejandro Piris, Javier Carmona, Gady Goldsobel, Ulrich Kintscher, Peter Vandenberghe, Isabelle Huys, Bart Geers, Reuben Benjamin, Victoria Potter, Chiara Bonini, Fabio Ciceri, Gianvito Martino, Reno Debets, Hugo P.H.M. van der Kuy, Stephan Mielke, Pontus Blomberg, Ewa Ellis, Antonia M.S. Müller, Nina Worel, Annette Künkele
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-07-01
Col·lecció:	The Lancet Regional Health. Europe
Matèries:	Advanced therapy medicinal products (ATMPs) Equitable clinical implementation of ATMPs Regulatory framework for ATMPs Clinical development of ATMPs Manufacturing of ATMPs Reimbursement of ATMPs
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666776226001006
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!